1. Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE). (25th November 2020) Authors: Tanaka, A; Hisauchi, I; Taguchi, I; Sezai, A; Toyoda, S; Tomiyama, H; Sata, M; Ueda, S; Oyama, J; Kitakaze, M; Murohara, T; Node, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗